Hangzhou Noya Medtech

Hangzhou Noya Medtech has developed the NoYA™ Radiofrequency Interatrial Shunt System—a minimally invasive medical device designed to treat chronic heart failure patients with elevated left atrial pressure. The system uses radiofrequency ablation to create an interatrial shunt without leaving an implantable stent. Early clinical results from first-in-human and multi-center studies indicate that the procedure can be performed safely and may improve symptoms in patients with HFpEF or HFmEF by reducing left atrial pressure. The RAISE trial demonstrated successful procedures in all enrolled patients, showing promising safety and efficacy signals at six months follow-up.